A Multicenter, Randomized, Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Deucravacitinib (BMS-986165) in Pediatric Subjects with Moderate to Severe Plaque Psoriasis

  • Lai, Francis (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

HREC Reference: 2022/ETH02701
NMA/ERM Reference Number: 95222
Monash Health Reference: RES-23-0000-315X
StatusActive
Effective start/end date22/06/23 → 21/06/28